Arizona 2022 2022 Regular Session

Arizona Senate Bill SB1467 Introduced / Bill

Filed 01/26/2022

                    REFERENCE TITLE: AHCCCS; drug treatment; testing; reporting             State of Arizona Senate Fifty-fifth Legislature Second Regular Session 2022           SB 1467           Introduced by  Senator Barto        AN ACT   Amending Title 36, chapter 29, article 1, Arizona Revised Statutes, by adding section 36-2907.03; relating to the Arizona health care cost containment system.     (TEXT OF BILL BEGINS ON NEXT PAGE)   

 

 

 

REFERENCE TITLE: AHCCCS; drug treatment; testing; reporting
State of Arizona Senate Fifty-fifth Legislature Second Regular Session 2022
SB 1467
Introduced by  Senator Barto

REFERENCE TITLE: AHCCCS; drug treatment; testing; reporting

 

 

 

 

State of Arizona

Senate

Fifty-fifth Legislature

Second Regular Session

2022

 

 

 

SB 1467

 

Introduced by 

Senator Barto

 

 

AN ACT

 

Amending Title 36, chapter 29, article 1, Arizona Revised Statutes, by adding section 36-2907.03; relating to the Arizona health care cost containment system.

 

 

(TEXT OF BILL BEGINS ON NEXT PAGE)

 

 Be it enacted by the Legislature of the State of Arizona: Section 1. Title 36, chapter 29, article 1, Arizona Revised Statutes, is amended by adding section 36-2907.03, to read: START_STATUTE36-2907.03. DNA-matched drug testing; requirements; annual report A. In any substance use disorder treatment provided pursuant to this article, the administration shall require contractors to implement random DNA-matched drug testing for a member who has graduated from an treatment program funded by the administration, unless the member is on probation or parole. The drug testing must occur at least two times each month for six months IMMEDIATELY following graduation from the treatment program and include testing for psychotropic medications. B. On or before October 1, 2023 and on or before October 1 of each year thereafter, The administration shall submit a report to the governor, the president of the senate, the speaker of the house of representatives and the chairpersons of the health and human services committees in the senate and the house of REPRESENTATIVES, or their successor committees, and shall provide a copy of the report to the secretary of state. The report shall include the following information for the preceding year relating to substance use disorder treatment programs funded by the administration: 1. The total number of graduated members and the members' employment status, indicating full-time or part-time employment.  2. The percentage of graduated members who relapsed within the six-month tracking period that is verified by the required DNA-matched drug testing. 3. The number of graduated members who are the subject of the department of child services oversight, including the number of those members who are parents who are engaged in reunification or have been reunified with their children. 4. The number of graduated members who returned to an administration-funded drug treatment program within six months after graduation.  5. The number of graduated members who are enrolled in school full time or part time. 6. The number of graduated members who are enrolled in job skills training. 7. The number of graduated members who are housed and who have their own lease or mortgage. 8. The number of graduated members who live with a friend or family member. 9. The number of graduated members who identify as homeless. END_STATUTE 

Be it enacted by the Legislature of the State of Arizona:

Section 1. Title 36, chapter 29, article 1, Arizona Revised Statutes, is amended by adding section 36-2907.03, to read:

START_STATUTE36-2907.03. DNA-matched drug testing; requirements; annual report

A. In any substance use disorder treatment provided pursuant to this article, the administration shall require contractors to implement random DNA-matched drug testing for a member who has graduated from an treatment program funded by the administration, unless the member is on probation or parole. The drug testing must occur at least two times each month for six months IMMEDIATELY following graduation from the treatment program and include testing for psychotropic medications.

B. On or before October 1, 2023 and on or before October 1 of each year thereafter, The administration shall submit a report to the governor, the president of the senate, the speaker of the house of representatives and the chairpersons of the health and human services committees in the senate and the house of REPRESENTATIVES, or their successor committees, and shall provide a copy of the report to the secretary of state. The report shall include the following information for the preceding year relating to substance use disorder treatment programs funded by the administration:

1. The total number of graduated members and the members' employment status, indicating full-time or part-time employment. 

2. The percentage of graduated members who relapsed within the six-month tracking period that is verified by the required DNA-matched drug testing.

3. The number of graduated members who are the subject of the department of child services oversight, including the number of those members who are parents who are engaged in reunification or have been reunified with their children.

4. The number of graduated members who returned to an administration-funded drug treatment program within six months after graduation. 

5. The number of graduated members who are enrolled in school full time or part time.

6. The number of graduated members who are enrolled in job skills training.

7. The number of graduated members who are housed and who have their own lease or mortgage.

8. The number of graduated members who live with a friend or family member.

9. The number of graduated members who identify as homeless. END_STATUTE